Leukotriene B4

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLeukotriene B4
Drug Alias NameLTB4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene B4 receptor agonists
TargetsLeukotriene B4 receptor
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLtb4 Sweden Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLtb4 Sweden Ab
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG